0000784199-23-000058.txt : 20230301 0000784199-23-000058.hdr.sgml : 20230301 20230301184957 ACCESSION NUMBER: 0000784199-23-000058 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230223 FILED AS OF DATE: 20230301 DATE AS OF CHANGE: 20230301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEE DAVID ASHLEY CENTRAL INDEX KEY: 0001112830 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13165 FILM NUMBER: 23695669 MAIL ADDRESS: STREET 1: C/O CRYOLIFE INC STREET 2: 1655 ROBERTS BLVD NW CITY: KENNESAW STATE: GA ZIP: 30144 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARTIVION, INC. CENTRAL INDEX KEY: 0000784199 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 592417093 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1655 ROBERTS BOULEVARD N W CITY: KENNESAW STATE: GA ZIP: 30144 BUSINESS PHONE: 7704193355 MAIL ADDRESS: STREET 1: 1655 ROBERTS BOULEVARD N W CITY: KENNESAW STATE: GA ZIP: 30144 FORMER COMPANY: FORMER CONFORMED NAME: CRYOLIFE INC DATE OF NAME CHANGE: 19940526 4 1 wf-form4_167771458039755.xml FORM 4 X0306 4 2023-02-23 0 0000784199 ARTIVION, INC. AORT 0001112830 LEE DAVID ASHLEY ARTIVION, INC. 1655 ROBERTS BLVD, NW KENNESAW GA 30144 0 1 0 0 Executive VP, COO & CFO Common Stock 2023-02-23 4 A 0 4713 0 A 337011 D Common Stock 2023-02-27 4 S 0 1492 12.938 D 335519 D Common Stock 2023-02-23 4 A 0 10122 0 A 345641 D Common Stock 2023-02-27 4 S 0 1602 12.938 D 344039 D Common Stock 22560 I *Indirect shares owned by Spouse (5,000), Shares to DAL Trust (17,560) Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023. These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date. /s/ David Ashley Lee 2023-02-28